Telecom Healthcare Sector

Aytu BioPharma

Market Cap: US$12.3m

A pharmaceutical company, focuses on commercializing novel therapeutics drugs in the United States and internationally.

Aspire Biopharma Holdings

Market Cap: US$12.2m

An early-stage biopharmaceutical company, engages in development and marketing of disruptive technology for novel sublingual delivery mechanisms in the United States.

PreveCeutical Medical

Market Cap: CA$17.0m

A health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products.

Marker Therapeutics

Market Cap: US$12.1m

A clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications.

EOM Pharmaceuticals Holdings

Market Cap: US$12.0m

Immunocellular Therapeutics, Ltd., a clinical-stage pharmaceutical company, focuses on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases.

Bioxytran

Market Cap: US$12.0m

A clinical stage pharmaceutical company, focuses on the development, manufacture, and commercialization of therapeutic drugs to address hypoxia in humans.

Meihua International Medical Technologies

Market Cap: US$12.0m

Meihua International Medical Technologies Co., Ltd.

Induction Healthcare Group

Market Cap: UK£8.9m

Provides software to healthcare professionals in the United Kingdom.

BioRestorative Therapies

Market Cap: US$11.9m

Develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells.

Welsis

Market Cap: US$11.8m

A development stage startup company, engages in the provision of online psychological help services.

DiagnosTear Technologies

Market Cap: CA$16.5m

An ophthalmic company, engages in developing and commercializing disruptive diagnostic solutions for eye diseases.

Red White & Bloom Brands

Market Cap: CA$16.5m

Manufactures, processes, and distributes cannabis products and accessories in the United States and Canada.

Biotricity

Market Cap: US$11.8m

A medical technology company, provides biometric data monitoring solutions in the United States.

OncoSil Medical

Market Cap: AU$18.4m

A medical device company, develops and commercializes localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma in Australia, New Zealand, and Europe.

Cellectar Biosciences

Market Cap: US$11.8m

A clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer in the United States.

Cosmos Health

Market Cap: US$11.7m

Manufactures, develops, and trades branded nutraceutical products in Greece, the United States, Croatia, Bulgaria, Ireland, the Cayman Islands, the UAE, the United Kingdom, and Cyprus.

Aesthetic Medical International Holdings Group

Market Cap: US$11.7m

Provides aesthetic medical services in the People’s Republic of China and Singapore.

Numinus Wellness

Market Cap: CA$16.1m

Provides psychedelic-assisted psychotherapy products and services in Canada and the United States.

Resonance Health

Market Cap: AU$17.9m

A healthcare technology and services company, designs, develops, manufactures, and commercializes software-as-medical devices in Australia, the Asia Pacific, North America, Europe, the Middle East, and Africa.

Enlitic

Market Cap: AU$17.8m

Operates in the healthcare sector in the United States, Europe, and Japan.

NuGen Medical Devices

Market Cap: CA$15.9m

A specialty medical device company, develops and commercializes novel drug delivery technologies in Europe, Asia, North America, Canada, and internationally.

IN8bio

Market Cap: US$11.3m

A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T cell product candidates for the treatment of cancer and autoimmune diseases.

Sirona Biochem

Market Cap: CA$15.8m

A cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France.

genedrive

Market Cap: UK£8.4m

Engages in the design, development, and manufacture of molecular diagnostics testing equipment for use in genotyping, pathogen detection, infectious disease detection, and other clinical indications.

COSCIENS Biopharma

Market Cap: CA$15.7m

A life science company, engages in developing and commercializing products for the cosmeceutical, nutraceutical and pharmaceutical markets in the United States, Germany, Columbia, the United Kingdom, and internationally.

Rhythm Biosciences

Market Cap: AU$17.6m

A medical diagnostics company, provides blood tests for the detection of cancers in Australia.

Bionano Genomics

Market Cap: US$11.2m

Provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants.

ImExHS

Market Cap: AU$17.5m

Offers cloud-based medical imaging solutions in Australia and internationally.

Hoth Therapeutics

Market Cap: US$11.2m

A clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs.

BioCardia

Market Cap: US$11.2m

A clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States.

Cell Source

Market Cap: US$11.2m

A biotechnology company, engages in developing cell therapy treatments based on the management of immune tolerance.

SeaStar Medical Holding

Market Cap: US$11.0m

A commercial-stage medical device company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States.

CS Diagnostics

Market Cap: US$11.0m

Manufactures and sells medical products for medicine, radiology, cardiology, and radiation therapy in Germany and internationally.

Firebrick Pharma

Market Cap: AU$17.1m

Engages in the development and commercializing of novel formulations for the uses of povidone iodine in Australia.

LexaGene Holdings

Market Cap: CA$14.8m

LexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems.

Dogwood Therapeutics

Market Cap: US$10.9m

A development-stage biotechnology company, focuses on the development of medicine to treat pain and fatigue-related disorders.